{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Death%3B+Neonatal&page=2", "query": { "condition": "Death; Neonatal", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Death%3B+Neonatal&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-06-10T16:08:33.989Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01506141", "title": "An Extension Study of HGT-HIT-045 Evaluating Long-Term Safety and Clinical Outcomes of Idursulfase-IT in Conjunction With Elaprase in Pediatric Participants With Hunter Syndrome and Cognitive Impairment", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Hunter Syndrome" ], "interventions": [ { "name": "Idursulfase-IT", "type": "DRUG" }, { "name": "Elaprase", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Takeda", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "3 Years", "maximum_age": "18 Years", "sex": "MALE", "summary": "3 Years to 18 Years · Male only" }, "enrollment_count": 15, "start_date": "2010-08-01", "completion_date": "2024-04-30", "has_results": true, "last_update_posted_date": "2025-08-06", "last_synced_at": "2026-06-10T16:08:33.989Z", "location_count": 7, "location_summary": "Chicago, Illinois • Chapel Hill, North Carolina • Portland, Oregon + 4 more", "locations": [ { "city": "Chicago", "state": "Illinois" }, { "city": "Chapel Hill", "state": "North Carolina" }, { "city": "Portland", "state": "Oregon" }, { "city": "Pittsburgh", "state": "Pennsylvania" }, { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT01506141" }, { "nct_id": "NCT04251026", "title": "A Study of Tividenofusp Alfa (DNL310) in Pediatric Participants With Hunter Syndrome", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Mucopolysaccharidosis II" ], "interventions": [ { "name": "tividenofusp alfa", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Denali Therapeutics Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "18 Years", "sex": "MALE", "summary": "Up to 18 Years · Male only" }, "enrollment_count": 47, "start_date": "2020-07-16", "completion_date": "2031-02", "has_results": false, "last_update_posted_date": "2025-08-07", "last_synced_at": "2026-06-10T16:08:33.989Z", "location_count": 4, "location_summary": "Oakland, California • Chicago, Illinois • Chapel Hill, North Carolina + 1 more", "locations": [ { "city": "Oakland", "state": "California" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Chapel Hill", "state": "North Carolina" }, { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT04251026" }, { "nct_id": "NCT06109181", "title": "Gene Therapy for ACM Due to a PKP2 Pathogenic Variant", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Arrhythmogenic Cardiomyopathy", "PKP2-ACM", "PKP2-ARVC" ], "interventions": [ { "name": "LX2020", "type": "GENETIC" } ], "intervention_types": [ "GENETIC" ], "sponsor": "Lexeo Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 10, "start_date": "2024-02-29", "completion_date": "2027-03", "has_results": false, "last_update_posted_date": "2025-11-12", "last_synced_at": "2026-06-10T16:08:33.989Z", "location_count": 5, "location_summary": "Stanford, California • Baltimore, Maryland • Ann Arbor, Michigan + 2 more", "locations": [ { "city": "Stanford", "state": "California" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Ann Arbor", "state": "Michigan" }, { "city": "Rochester", "state": "New York" }, { "city": "Charleston", "state": "South Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT06109181" }, { "nct_id": "NCT06980025", "title": "Aspirin Dose Escalation for the Prevention of Recurrent Preterm Delivery Trial", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Preterm Delivery", "Obstetrical Complications" ], "interventions": [ { "name": "162mg Aspirin", "type": "DRUG" }, { "name": "81mg Aspirin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "The George Washington University Biostatistics Center", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "14 Years", "maximum_age": null, "sex": "FEMALE", "summary": "14 Years and older · Female only" }, "enrollment_count": 1800, "start_date": "2025-07-01", "completion_date": "2029-02-28", "has_results": false, "last_update_posted_date": "2026-04-09", "last_synced_at": "2026-06-10T16:08:33.989Z", "location_count": 14, "location_summary": "Birmingham, Alabama • San Francisco, California • Chicago, Illinois + 10 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "San Francisco", "state": "California" }, { "city": "Chicago", "state": "Illinois" }, { "city": "New York", "state": "New York" }, { "city": "Chapel Hill", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT06980025" }, { "nct_id": "NCT03049254", "title": "Mayo AVC Registry and Biobank", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Arrhythmogenic Right Ventricular Cardiomyopathy", "Cardiomyopathies", "Heart Diseases", "Cardiovascular Diseases", "Sudden Cardiac Arrest", "Sudden Cardiac Death", "Arrhythmogenic Right Ventricular Dysplasia", "Arrhythmogenic Ventricular Cardiomyopathy", "Familial Dilated Cardiomyopathy", "Cardiovascular Abnormalities", "Sarcoidosis", "Cardiac Arrhythmia", "Cardiac Sarcoidosis", "Myocarditis", "Inflammatory Cardiomyopathy", "Ventricular Tachycardia", "Right Ventricular Outflow Tract Ventricular Tachycardia" ], "interventions": [], "intervention_types": [], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 1000, "start_date": "2018-02-09", "completion_date": "2027-03", "has_results": false, "last_update_posted_date": "2026-04-27", "last_synced_at": "2026-06-10T16:08:33.989Z", "location_count": 1, "location_summary": "Rochester, Minnesota", "locations": [ { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT03049254" }, { "nct_id": "NCT00027196", "title": "Signs and Symptoms Associated With Molecular Defects in Genetically Inherited Heart Disease", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Congenital Heart Defect" ], "interventions": [], "intervention_types": [], "sponsor": "National Heart, Lung, and Blood Institute (NHLBI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 9999999, "start_date": "1998-04", "completion_date": "2003-04", "has_results": false, "last_update_posted_date": "2008-03-04", "last_synced_at": "2026-06-10T16:08:33.989Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00027196" }, { "nct_id": "NCT01653392", "title": "BioThrax® (Anthrax) Vaccine in Pregnancy Registry", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Pregnancy Complications", "Pregnancy Outcome", "Congenital Abnormalities" ], "interventions": [ { "name": "Observational Intervention", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Emergent BioSolutions", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "FEMALE", "summary": "Female only" }, "enrollment_count": 98, "start_date": "2012-07", "completion_date": "2020-02", "has_results": false, "last_update_posted_date": "2024-03-15", "last_synced_at": "2026-06-10T16:08:33.989Z", "location_count": 1, "location_summary": "San Diego, California", "locations": [ { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01653392" }, { "nct_id": "NCT00654433", "title": "ALD-101 Adjuvant Therapy of Unrelated Umbilical Cord Blood Transfusion (UCBT) in Patients With Inherited Metabolic Diseases", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Inherited Metabolic Diseases", "Lysosomal Storage Disorders", "Peroxisomal Storage Diseases", "Inborn Errors of Metabolism", "Mucopolysaccharidosis" ], "interventions": [ { "name": "ALD-101", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Aldagen", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "16 Years", "sex": "ALL", "summary": "Up to 16 Years" }, "enrollment_count": 40, "start_date": "2008-03", "completion_date": "2011-11", "has_results": false, "last_update_posted_date": "2014-07-08", "last_synced_at": "2026-06-10T16:08:33.989Z", "location_count": 3, "location_summary": "Los Angeles, California • New York, New York • Durham, North Carolina", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "New York", "state": "New York" }, { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT00654433" }, { "nct_id": "NCT07050160", "title": "Long-term Follow-up Study of Gene Therapy for Arrhythmogenic Cardiomyopathy Due to a Plakophilin-2 Pathogenic Variant", "overall_status": "ENROLLING_BY_INVITATION", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Arrhythmogenic Cardiomyopathy", "PKP2-ACM", "PKP2-ARVC" ], "interventions": [], "intervention_types": [], "sponsor": "Lexeo Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "67 Years", "sex": "ALL", "summary": "18 Years to 67 Years" }, "enrollment_count": 10, "start_date": "2025-08-29", "completion_date": "2030-08", "has_results": false, "last_update_posted_date": "2025-11-12", "last_synced_at": "2026-06-10T16:08:33.989Z", "location_count": 1, "location_summary": "Ann Arbor, Michigan", "locations": [ { "city": "Ann Arbor", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT07050160" }, { "nct_id": "NCT02108028", "title": "Study of Voicing My CHOiCES as a Tool for Advanced Care Planning in Young Adults With Cancer", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "HIV", "Cancer", "Chronic Granulomatous Disease", "Dock 8 Deficiency" ], "interventions": [], "intervention_types": [], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 272, "start_date": "2014-04-03", "completion_date": "2024-07-24", "has_results": false, "last_update_posted_date": "2026-06-01", "last_synced_at": "2026-06-10T16:08:33.989Z", "location_count": 9, "location_summary": "Orange, California • Washington D.C., District of Columbia • Tampa, Florida + 6 more", "locations": [ { "city": "Orange", "state": "California" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Tampa", "state": "Florida" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT02108028" } ] }